Suchergebnisse - "de Miguel-Perez, Diego"

PubPharm (49)

1

Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von de Miguel-Perez, D. | Ak, M. | Mamindla, P. | +12

2

Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC

enthalten in: Journal of experimental & clinical cancer research | 2024

von de Miguel‑Perez, D. | Ak, M. | Mamindla, P. | +12

3

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von de Miguel-Perez, D. | Pickering, E. | Malapelle, U. | +19

4

Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer

enthalten in: Biomarker research | 2023

von de Miguel-Perez, D. | Ortega, F. | Tejada, R. | +10

5

Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy : Management of C797S Acquired Mutation

enthalten in: Clinical lung cancer | 2023

von Russo, A. | Scilla, K. | Mehra, R. | +7

6

Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer

enthalten in: Vaccines | 2023

von Hernández-Pedro, N. | Arroyo-Hernández, M. | Barrios-Bernal, P. | +8

7

Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Cucchiara, F. | Crucitta, S. | Petrini, I. | +6

8

Predictive Capability of PD-L1 Protein Expression for Patients With Advanced NSCLC : Any Differences Based on Histology?

enthalten in: Clinical lung cancer | 2023

von Meshulami, N. | Tavolacci, S. | de Miguel-Perez, D. | +3

9

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) : Results of an Observational Longitudinal Cohort Study

enthalten in: Targeted oncology | 2023

von Chamorro, D. | Cardona, A. | Rodríguez, J. | +35

10

Baseline extracellular vesicle TGF-β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non-small cell lung cancer

enthalten in: Cancer | 2023

von de Miguel-Perez, D. | Russo, A. | Gunasekaran, M. | +16

1
2
3
4
5
Nächster »
[5]